ClinicalTrials.Veeva

Menu

Adolescent Attention to Emotion Study

University of Pittsburgh logo

University of Pittsburgh

Status

Completed

Conditions

Depression

Treatments

Other: Neurofeedback

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04105868
STUDY19010063
K23MH119225 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Rates of depression increase rapidly during adolescence, especially for girls, and, thus, research is needed to spur the development of novel interventions to prevent adolescent depression. This project seeks to determine if a novel visuocortical probe of affect-biased attention (i.e., steady-state visual evoked potentials derived from EEG) can 1) be used to prospectively predict depression using a multi-wave repeated measures design and 2) modify affect-biased attention and buffer subsequent mood reactivity using real time neurofeedback. This work could ultimately lead to improved identification of adolescents who are at high risk for depression and directly inform the development of mechanistic treatment targets to be used in personalized intervention prescriptions for high-risk youth.

Enrollment

15 patients

Sex

Female

Ages

13 to 15 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participants will include 90 female adolescents ages 13 years 0 months through 15 years 11 months at study entry.

Exclusion criteria

  1. Lifetime history of any Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 depressive disorder
  2. Lifetime history of taking antidepressants [e.g., selective serotonin reuptake inhibitor (SSRIs)]
  3. Lifetime history of a DSM 5 psychotic, bipolar, or autistic spectrum disorder.
  4. Presence of EEG contraindications (e.g., personal lifetime history of seizures or family history of hereditary epilepsy).
  5. Being pre-pubertal
  6. Lifetime history of a neurological or serious medical condition.
  7. Lifetime history of head injury or congenital neurological anomalies (based on parent report).
  8. Intelligence quotient (IQ) less than 80, as assessed using the Wechsler Abbreviated Scale of Intelligence (WASI).
  9. Uncorrected visual disturbance
  10. Being acutely suicidal or at risk for harm to self or others.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Neurofeedback
Experimental group
Description:
Participants will receive feedback about their attention to negative distractors during each trial using activity from their brain waves, which will help them reduce their attention to distractors.
Treatment:
Other: Neurofeedback

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Mary Woody, PhD; Nastasia McDonald, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems